Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma

被引：643

作者：

Lian, Christine Guo ^{[1
,2
]}

Xu, Yufei ^{[2
]}

Ceol, Craig ^{[3
,6
]}

Wu, Feizhen ^{[9
]}

Larson, Allison ^{[5
]}

Dresser, Karen ^{[7
]}

Xu, Wenqi ^{[9
]}

Tan, Li ^{[9
]}

Hu, Yeguang ^{[2
]}

Zhan, Qian ^{[1
]}

Lee, Chung-wei ^{[1
]}

Hu, Di ^{[2
]}

Lian, Bill Q. ^{[2
,8
]}

Kleffel, Sonja ^{[5
]}

Yang, Yijun ^{[10
]}

Neiswender, James ^{[6
]}

Khorasani, Abraham J. ^{[2
]}

Fang, Rui ^{[2
]}

Lezcano, Cecilia ^{[1
]}

Duncan, Lyn M. ^{[4
]}

Scolyer, Richard A. ^{[11
,12
]}

Thompson, John F. ^{[11
,12
]}

Kakavand, Hojabr ^{[11
,12
]}

Houvras, Yariv ^{[3
,13
,14
,15
]}

Zon, Leonard I. ^{[3
]}

Mihm, Martin C., Jr. ^{[5
]}

Kaiser, Ursula B. ^{[2
]}

Schatton, Tobias ^{[5
]}

Woda, Bruce A. ^{[7
]}

Murphy, George F. ^{[1
]}

Shi, Yujiang G. ^{[2
,9
]}

机构：

[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Dermatopathol,Dept Pathol, Boston, MA 02115 USA

[2] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens,Dept Med, Boston, MA 02115 USA

[3] Harvard Univ, Sch Med, Howard Hughes Med Inst,Harvard Stem Cell Inst, Stem Cell Program & Hematol Oncol,Childrens Hosp, Boston, MA 02115 USA

[4] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Dermatopathol,Dept Pathol, Boston, MA 02115 USA

[5] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA

[6] Univ Massachusetts, Dept Canc Biol, Worcester, MA 01605 USA

[7] Univ Massachusetts, Dept Pathol, Worcester, MA 01605 USA

[8] Univ Massachusetts, Dept Med, Worcester, MA 01605 USA

[9] Fudan Univ, Inst Biomed Sci, Lab Epigenet, Shanghai 200032, Peoples R China

[10] ZIOPHARM Oncol Inc, Charlestown, MA 02129 USA

[11] Univ Sydney, Melanoma Inst Australia, Royal Prince Alfred Hosp, Sydney, NSW 2006, Australia

[12] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia

[13] Weill Cornell Med Coll, Dept Surg, New York, NY 10065 USA

[14] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA

[15] New York Presbyterian Hosp, New York, NY 10065 USA

来源：

CELL | 2012年 / 150卷 / 06期

基金：

美国国家卫生研究院;

关键词：

GENE-EXPRESSION; DNA-METHYLATION; ONCOMETABOLITE; 2-HYDROXYGLUTARATE; CELL-LINES; 5-METHYLCYTOSINE; MUTATIONS; TET1; DIFFERENTIATION; IDENTIFICATION; PROGRESSION;

D O I：

10.1016/j.cell.2012.07.033

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

DNA methylation at the 5 position of cytosine (5-mC) is a key epigenetic mark that is critical for various biological and pathological processes. 5-mC can be converted to 5-hydroxymethylcytosine (5-hmC) by the ten-eleven translocation (TET) family of DNA hydroxylases. Here, we report that "loss of 5-hmC'' is an epigenetic hallmark of melanoma, with diagnostic and prognostic implications. Genome-wide mapping of 5-hmC reveals loss of the 5-hmC landscape in the melanoma epigenome. We show that downregulation of isocitrate dehydrogenase 2 (IDH2) and TET family enzymes is likely one of the mechanisms underlying 5-hmC loss in melanoma. Rebuilding the 5-hmC landscape in melanoma cells by reintroducing active TET2 or IDH2 suppresses melanoma growth and increases tumor-free survival in animal models. Thus, our study reveals a critical function of 5-hmC in melanoma development and directly links the IDH and TET activity-dependent epigenetic pathway to 5-hmC-mediated suppression of melanoma progression, suggesting a new strategy for epigenetic cancer therapy.

引用

页码：1135 / 1146

页数：12

共 36 条

[11] Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification [J].

Ito, Shinsuke ;

D'Alessio, Ana C. ;

Taranova, Olena V. ;

Hong, Kwonho ;

Sowers, Lawrence C. ;

Zhang, Yi .

NATURE, 2010, 466 (7310) :1129-U151

[12] Recent trends in cutaneous melanoma incidence among whites in the United States [J].

Jemal, A ;

Devesa, SS ;

Hartge, P ;

Tucker, MA .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (09) :678-683

[13] Cancer statistics, 2006 [J].

Jemal, A ;

Siegel, R ;

Ward, E ;

Murray, T ;

Xu, JQ ;

Smigal, C ;

Thun, MJ .

CA-A CANCER JOURNAL FOR CLINICIANS, 2006, 56 (02) :106-130

[14] Integrative Genome Comparison of Primary and Metastatic Melanomas [J].

Kabbarah, Omar ;

Nogueira, Cristina ;

Feng, Bin ;

Nazarian, Rosalynn M. ;

Bosenberg, Marcus ;

Wu, Min ;

Scott, Kenneth L. ;

Kwong, Lawrence N. ;

Xiao, Yonghong ;

Cordon-Cardo, Carlos ;

Granter, Scott R. ;

Ramaswamy, Sridhar ;

Golub, Todd ;

Duncan, Lyn M. ;

Wagner, Stephan N. ;

Brennan, Cameron ;

Chin, Lynda .

PLOS ONE, 2010, 5 (05)

[15] Screen for IDH1, IDH2, IDH3, D2HGDH and L2HGDH Mutations in Glioblastoma [J].

Krell, Daniel ;

Assoku, Mawuelikem ;

Galloway, Malcolm ;

Mulholland, Paul ;

Tomlinson, Ian ;

Bardella, Chiara .

PLOS ONE, 2011, 6 (05)

[16] Acquired mutations in TET2 are common in myelodysplastic syndromes [J].

Langemeijer, Saskia M. C. ;

Kuiper, Roland P. ;

Berends, Marieke ;

Knops, Ruth ;

Aslanyan, Mariam G. ;

Massop, Marion ;

Stevens-Linders, Ellen ;

van Hoogen, Patricia ;

van Kessel, Ad Geurts ;

Raymakers, Reinier A. P. ;

Kamping, Eveline J. ;

Verhoef, Gregor E. ;

Verburgh, Estelle ;

Hagemeijer, Anne ;

Vandenberghe, Peter ;

de Witte, Theo ;

van der Reijden, Bert A. ;

Jansen, Joop H. .

NATURE GENETICS, 2009, 41 (07) :838-U102

[17] Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling [J].

Liu, Suhu ;

Ren, Suping ;

Howell, Paul ;

Fodstad, Oystein ;

Riker, Adam I. .

PIGMENT CELL & MELANOMA RESEARCH, 2008, 21 (05) :545-558

[18] Epidemiology of melanoma [J].

Marks, R .

CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2000, 25 (06) :459-463

[19]

Paz MF, 2003, CANCER RES, V63, P1114

[20] Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome [J].

Reitman, Zachary J. ;

Jin, Genglin ;

Karoly, Edward D. ;

Spasojevic, Ivan ;

Yang, Jian ;

Kinzler, Kenneth W. ;

He, Yiping ;

Bigner, Darell D. ;

Vogelstein, Bert ;

Yan, Hai .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (08) :3270-3275

← 1 2 3 4 →